| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |